Intercede’s MyIDaaS Eliminates Workplace Passwords
6.6.2017 11:01 | Business Wire
Today, digital identity and credentials expert Intercede announced MyID as a Service (MyIDaaS), a convenient and affordable cloud-based ‘strong credentials’ service for enterprises. With 25% of breaches involving ‘internal actors’, and 81% of hacking related breaches exploiting stolen or weak passwords1, user authentication is currently the weakest link in the security chain and the potential for catastrophic business impact is real.
To navigate this environment, MyIDaaS removes the need for passwords completely, replacing them with unique, highly secure, government-grade digital identities and an authentication process that enhances the user experience. Critically, MyIDaaS is designed to provide this level of security in a cost-effective manner, allowing enterprises to strengthen authentication methods without compromising budgets.
Recognising the vulnerabilities associated with today’s digital economy, regulators across the world are establishing rules to ensure that security not only catches up with internet development but seeks to “future proof” interconnectivity from emerging threats.
For example in the US, President Trump’s Executive Order on Cybersecurity requires public and private providers of critical infrastructure and digital services to ensure that the highest recommended standards for cybersecurity are applied universally. This is manifest in New York State 23 NYCRR 500 Cybersecurity Requirements for Financial Services Companies. NIST Special Publication 800-171 for government contractors also mandates multi-factor authentication to ensure enhanced levels of identity assurance.
In Europe, the Second Payment Services Directive (PSD2), the General Data Protection Regulations (GDPR) and the Markets in Financial Instruments and Derivatives (MiFID II) Directive, all mandate enhanced levels of digital trust enabled by strong customer authentication. These international regulatory frameworks create a large global market for password replacement technologies, which MyIDaaS has been specifically designed to satisfy. By adhering to the most stringent of regulations all companies, regardless of sector and size, can meet compliance obligations quickly and with ease.
The latest solution from Intercede has been created by envisioning and reengineering the company’s existing MyID solution to operate as a secure, self-service, multi-tenanted Cloud service. It is designed to enable organizations to replace employee passwords with more secure and convenient digital identities on real or virtual smart cards, pluggable tokens, mobile devices and embedded security modules. The solution manages the lifecycle of credentials, for example revoking them if a user leaves an organization or updating them in advance of the credentials expiring.
“Regardless of the organization in question, weak or compromised credentials continue to be today’s security downfall. Usernames and passwords are the number one cause of the majority of data breaches. While there have been solutions to this problem for a number of years, most of them have been inaccessible to companies with limited IT budgets, scarce resources and a lack of in-house security skills,” said Richard Parris, CEO of Intercede.
“For over 20 years, Intercede has been at the forefront of securing some of the most sensitive and critical industries, including defense, aerospace, government and financial institutions. Through MyIDaaS, we’re now offering that same level of security to businesses, without the pain of infrastructure overhaul or hefty costs. This is a game changer for enterprises of all sizes who need to comply with new regulations for protecting customer information but lack the necessary budget and cyber security expertise to build their own digital trust solutions.”
MyID is currently deployed by governments and defense companies to secure some of the world’s most sensitive data. MyIDaaS brings that same government-grade security to businesses to significantly reduce their exposure to cyber-attack. The service packages digital credential deployment into an easily-consumed cloud service. Businesses using the service will be provided with a dedicated certification authority and the ability to deploy digital identities on to hardware-secured zones within existing enterprise computers and devices. This includes Intel Authenticate or IPT on Intel powered computers and Trusted Platform Modules on platforms running Microsoft operating systems. Future support for physical smart cards, smartphones and Internet-of-Things connected devices is planned.
Intercede® is a cybersecurity company specializing in identity, credential management and secure mobility to enable digital trust. It provides software and services that help organizations ensure the safety and security of their people, facilities, networks and information in an increasingly mobile, digital world.
Intercede has been delivering solutions to high profile customers, from the US and UK governments to some of the world’s largest corporations, telecommunications providers and information technology firms, for over 20 years. To find out more: www.intercede.com
Notes to editors:
- MyIDaaS can be deployed without businesses needing to make significant changes to the way existing users are managed. Instead, system administrators can define an Active Directory Security Group for each type of credential and privilege required. Users can then be added to these groups using existing management tools. The service also includes a dedicated, private Certification Authority, an OCSP responder so that businesses can immediately revoke access. A centralised dashboard can also help users keep track of activity.
- The MyIDaaS service can be subscribed to via a self-service portal, making it a highly scalable business proposition for Intercede and its enterprise customers to deliver and implement. Designed to support high volumes of individual enterprise customers, MyIDaaS is also available as an OEM service to partners who wish to embed a credential provisioning solution within their existing product portfolios.
1 Verizon 2017 Data Breach Report
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
IFF to Present at the Barclays Global Consumer Staples Conference21.8.2017 23:15 | Tiedote
Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF), a leading innovator of sensory experiences that move the world, today announced that Andreas Fibig, Chairman and Chief Executive Officer will present at the Barclays Global Consumer Staples Conference in Boston, MA on Thursday, September 7, 2017 at 11:15 a.m. EDT. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Meet IFF International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for explorati
Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform21.8.2017 23:11 | Tiedote
Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue regenerative therapies to address unmet medical needs in cancer and chronic and degenerative disease. Celularity completed their Series A financing with contributions from several biopharma companies, including Sorrento Therapeutics, United Therapeutics Corporation and Human Longevity, Inc., and entrepreneurial investors. Celularity has been created through the contributions of extensive intellectual property, clinical-stage assets, basic and clinical research, and development expertise including: Several clinical-stage immuno-oncology and regenerative medicine assets and a pipeline of pre-clinical assets Proprietary allogeneic (“readily accessible”) immunotherapy platform 200+ issued and pending patents in cell therapy
European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 16:25 | Tiedote
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the
IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 15:00 | Tiedote
IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman
PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 11:03 | Tiedote
PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate
Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 11:00 | Tiedote
Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme